뉴스
- OpenAI's Stargate project in Korea stuck at starting gate as Samsung, SK ... Last October, OpenAI CEO Sam Altman brought plans for a Korean leg of Stargate — an AI... broader OpenAI partnership with Samsung and SK announced last October — aimed at building two data...
- U.S.-N. Korea talks key to breaking stalemate: Seoul official South and North Korea remain technically at war, as the 1950-53 Korean War ended with an armistice. Scaling back the joint Ulchi Freedom Shield exercise, along with Trump's vagueness on whether...
- Nvidia Earnings, Rate Calls to Test Korean Stocks South Korean stocks face a series of major market events this week, with Nvidia's earnings, the...
- JW Pharma Jumps 15%, OliX Sinks 14% on Overhang Concerns[K-Bio Pulse] South Korean pharmaceutical and biotech stocks broadly traded lower, with JW Pharmaceutical and OliX
- Lee Kang-in marks Spain return with 1st goal for Atletico Madrid football-player Lee Kang-in marks Spain return with 1st goal for Atletico Madrid By Yoo Jee-ho SEOUL, Aug. 20 (Yonhap) -- South Korean midfielder Lee Kang-in celebrated his return to Spain by...
- Biotech Stocks Rally with Market Rebound; Orum Therapeutics Jumps 18% [K-Bio Pulse] On July 31, South Korean pharmaceutical and biotech stocks broadly advanced as domestic equities rebounded , with bargain hunting returning to beaten-down growth and biotech names.
- i-SENS Soars on Earnings, Peptron Rebounds, Cellid Hits Limit-Up[K-Bio Pulse] South Korean pharmaceutical and biotechnology stocks were mixed Monday, with i-SENS soaring after reporting
- Remedi Surges, HLB Hits Limit Down as FDA Blow Weighs[K-Bio Pulse] The Korean biotech sector saw sharply diverging performances on July 13, with newly listed Remedi. emerging
- Antrogen Slides on Japan Fears, Hanmi Science Gains[K-Bio Pulse] South Korean biopharmaceutical stocks moved in opposite directions on Tuesday, with Antrogen tumbling
- Peptron Sinks on Fading Lilly Hopes; Nature Cell, BL Pharmtech Hit Limit-Up [K-Bio Pulse] On July 9, South Korean pharmaceutical and biotech stocks saw sharply divergent moves, with Nature Cell
1 페이지
다음 →